J. Ferlay, C. Partensky, and F. Bray, More deaths from pancreatic cancer than breast cancer in the EU by 2017, Acta Oncol Stockh Swed, vol.55, pp.1158-1160, 2016.

L. Rahib, B. D. Smith, and R. Aizenberg, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, vol.74, pp.2913-2921, 2014.

C. Bony, A. Uhry, Z. Remontet, L. Guizard, A. V. Voirin et al., Grosclaude P -Survie des personnes atteintes de cancer en France métropolitaine 1989-2013. Etude à partir des registres des cancers du réseau Francim. Partie 1 : tumeurs solides -Santé Publique France. 4. van der Geest LGM, Lemmens VEPP, de Hingh IHJT, et al. Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer, Br J Surg, vol.104, pp.1568-1577, 2017.

L. Sabater, A. García-granero, and J. Escrig-sos, Outcome quality standards in pancreatic oncologic surgery, Ann Surg Oncol, vol.21, pp.1138-1146, 2014.

K. Chiang, C. Yeh, and S. Ueng, Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer, World J Surg Oncol, vol.10, p.77, 2012.

C. Catalano, A. Laghi, and F. Fraioli, Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability, Eur Radiol, vol.13, pp.149-156, 2003.

D. , L. Js, and B. , Predicting resectability of pancreatic head cancer with multidetector CT. Surgical and pathologic correlation, JOP J Pancreas, vol.8, pp.753-758, 2007.

C. Cassinotto, A. Mouries, and J. Lafourcade, Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy, Radiology, vol.273, pp.108-116, 2014.

M. Wagner, C. Antunes, and D. Pietrasz, CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma

, Eur Radiol, vol.27, pp.3104-3116, 2017.

M. Katz, Q. Shi, and S. A. Ahmad, Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101, JAMA Surg, vol.151, p.161137, 2016.

T. Michelakos, I. Pergolini, and C. Castillo, Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX, Ann Surg, vol.269, pp.733-740, 2019.

M. W. Müller, H. Friess, and J. Köninger, Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas, Am J Surg, vol.195, pp.221-228, 2008.

D. Dindo, N. Demartines, and P. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, vol.240, pp.205-213, 2004.

C. Bassi, G. Marchegiani, and C. Dervenis, The 2016 update of the International Study

, Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After, Surgery, vol.161, pp.584-591, 2017.

P. Sánchez-velázquez, X. Muller, and G. Malleo, Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons, Ann Surg, vol.270, pp.211-218, 2019.

C. R. Ferrone, G. Marchegiani, and T. S. Hong, Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer, Ann Surg, vol.261, pp.12-17, 2015.

G. Balzano, G. Capretti, and G. Callea, Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy, HPB, vol.18, pp.470-478, 2016.

B. Tingstedt, B. Andersson, and C. Jönsson, First results from the Swedish National Pancreatic and Periampullary Cancer Registry, HPB, vol.21, pp.34-42, 2019.

E. F. Yekebas, L. Wolfram, and G. Cataldegirmen, Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections, Ann Surg, vol.246, pp.269-280, 2007.

G. Rajarathinam, D. G. Kannan, and V. Vimalraj, Post pancreaticoduodenectomy haemorrhage: outcome prediction based on new ISGPS Clinical severity grading, HPB, vol.10, pp.363-370, 2008.

M. Vullierme, M. Ronot, and M. , Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study, AJR Am J Références

J. Ferlay, C. Partensky, and F. Bray, More deaths from pancreatic cancer than breast cancer in the EU by 2017, Acta Oncol Stockh Swed, vol.55, pp.1158-1160, 2016.

L. Rahib, B. D. Smith, and R. Aizenberg, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, vol.74, pp.2913-2921, 2014.

C. Bony, A. Uhry, Z. Remontet, L. Guizard, A. V. Voirin et al., Grosclaude P -Survie des personnes atteintes de cancer en France métropolitaine 1989-2013, Etude à partir des registres des cancers du réseau Francim. Partie 1 : tumeurs solides

K. Chiang, C. Yeh, and S. Ueng, Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer, World J Surg Oncol, vol.10, p.77, 2012.

T. Nakamura, T. Asano, and K. Okamura, A Preoperative Prognostic Scoring System to Predict Prognosis for Resectable Pancreatic Cancer: Who Will Benefit from Upfront Surgery?, J Gastrointest Surg Off J Soc Surg Aliment Tract, vol.23, pp.990-996, 2019.

C. Neuzillet, A. Sauvanet, and P. Hammel, Prognostic factors for resectable pancreatic adenocarcinoma, J Visc Surg, vol.148, pp.232-243, 2011.

O. Turrini, F. Paye, and P. Bachellier, Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, vol.39, pp.171-178, 2013.

T. Seufferlein, J. B. Bachet, and E. Van-cutsem, Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, vol.23, issue.7, pp.33-40, 2012.

J. R. Delpero, F. Jeune, and P. Bachellier, Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study, Ann Surg, vol.266, pp.787-796, 2017.

Z. Huang and F. Liu, Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis, Tumour Biol J Int Soc Oncodevelopmental Biol Med, vol.35, pp.7459-7465, 2014.

U. K. Ballehaninna and R. S. Chamberlain, The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal, J Gastrointest Oncol, vol.3, pp.105-119, 2012.

E. G. Chiorean, V. Hoff, D. D. Reni, and M. , CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer, Ann Oncol Off J Eur Soc Med Oncol, vol.27, pp.654-660, 2016.

Y. Kato, S. Takahashi, and N. Gotohda, Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer, J Gastrointest Surg Off J Soc Surg Aliment Tract, vol.20, pp.1435-1443, 2016.

S. Hata, Y. Sakamoto, and Y. Yamamoto, Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer, Ann Surg Oncol, vol.19, pp.636-641, 2012.

N. Kondo, Y. Murakami, and K. Uemura, Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer, Ann Surg Oncol, vol.17, pp.2321-2329, 2010.

M. M. Al-hawary, I. R. Francis, and S. T. Chari, Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association, Gastroenterology, vol.146, pp.291-304, 2014.

W. J. Eshuis, O. Loohuis, K. M. Busch, and O. , Influence of aberrant right hepatic artery on perioperative course and longterm survival after pancreatoduodenectomy, HPB, vol.13, pp.161-167, 2011.

L. Sulpice, M. Rayar, and C. Paquet, Does an aberrant right hepatic artery really influence the short-and long-term results of a pancreaticoduodenectomy for malignant disease? A matched case-controlled study, J Surg Res, vol.185, pp.620-625, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00864265

O. Turrini, E. A. Wiebke, and J. R. Delpero, Preservation of replaced or accessory right hepatic artery during pancreaticoduodenectomy for adenocarcinoma: impact on margin status and survival, J Gastrointest Surg Off J Soc Surg Aliment Tract, vol.14, pp.1813-1819, 2010.

J. A. Glant, J. A. Waters, and M. G. House, Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma?, Surgery, vol.150, pp.607-616, 2011.

S. P. Raman, S. Reddy, and M. J. Weiss, Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer, AJR Am J Roentgenol, vol.204, pp.37-42, 2015.

, National Comprehensive Cancer Network. NCCN practice guidelines for pancreatic cancer, version 2, 2020.

M. Vullierme, M. Ronot, and M. , Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study, AJR Am J Roentgenol, vol.211, pp.217-225, 2018.

H. Mahaseth, E. Brutcher, and J. Kauh, Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma, Pancreas, vol.42, pp.1311-1315, 2013.

M. Katz, Q. Shi, and S. A. Ahmad, Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101, JAMA Surg, vol.151, p.161137, 2016.

J. R. Delpero, J. M. Boher, and A. Sauvanet, Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie, Ann Surg Oncol, vol.22, pp.1874-1883, 2015.

S. Heinrich, B. Pestalozzi, and M. Lesurtel, Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study), BMC Cancer, vol.11, p.346, 2011.

L. Schwarz, D. Vernerey, and J. Bachet, Resectable pancreatic adenocarcinoma neoadjuvant FOLF(IRIN)OX-based chemotherapy -a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study), BMC Cancer, vol.18, p.762, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01857797

D. Pietrasz, L. Marthey, and M. Wagner, Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort, Ann Surg Oncol, vol.22, issue.3, pp.1196-1205, 2015.

C. Cassinotto, A. Mouries, and J. Lafourcade, Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy, Radiology, vol.273, pp.108-116, 2014.

C. Catalano, A. Laghi, and F. Fraioli, Pancreatic carcinoma: the role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability, Eur Radiol, vol.13, pp.149-156, 2003.

D. , L. Js, and B. , Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation, JOP J Pancreas, vol.8, pp.753-758, 2007.

C. Cassinotto, J. Cortade, and G. Belleannée, An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment, Eur J Radiol, vol.82, pp.589-593, 2013.

M. Wagner, C. Antunes, and D. Pietrasz, CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma, Eur Radiol, vol.27, pp.3104-3116, 2017.

V. B. Allen, K. S. Gurusamy, and Y. Takwoingi, Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer, Cochrane Database Syst Rev, vol.7, p.9323, 2016.

S. K. Maithel, S. Maloney, and C. Winston, Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma, Ann Surg Oncol, vol.15, pp.3512-3520, 2008.

Z. V. Fong, D. Alvino, F. Castillo, and C. , Reappraisal of Staging Laparoscopy for Patients with Pancreatic Adenocarcinoma: A Contemporary Analysis of 1001 Patients, Ann Surg Oncol, vol.24, pp.3203-3211, 2017.

N. M. Sell, Z. V. Fong, D. Castillo, and C. F. , Staging Laparoscopy Not Only Saves Patients an Incision, But May Also Help Them Live Longer, Ann Surg Oncol, vol.25, pp.1009-1016, 2018.

S. Paiella, M. Sandini, and L. Gianotti, The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, vol.42, pp.616-624, 2016.

T. Yoshida, T. Matsumoto, and A. Sasaki, Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma, Am J Surg, vol.187, pp.736-740, 2004.

U. Marchese, J. Ewald, and M. Gilabert, Outcomes of pancreatic adenocarcinoma that was not resected because of isolated para-aortic lymph node involvement, J Visc Surg, vol.156, pp.97-101, 2019.

L. Schwarz, R. M. Lupinacci, and M. Svrcek, Para-aortic lymph node sampling in pancreatic head adenocarcinoma, Br J Surg, vol.101, pp.530-538, 2014.

M. Sho, Y. Murakami, and F. Motoi, Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients, J Gastroenterol, vol.50, pp.694-702, 2015.

S. Yamada, A. Nakao, and T. Fujii, Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery?, Pancreas, vol.38, pp.13-17, 2009.

S. Hempel, V. Plodeck, and F. Mierke, Para-aortic lymph node metastases in pancreatic cancer should not be considered a watershed for curative resection, Sci Rep, vol.7, p.7688, 2017.

C. Agalianos, N. Gouvas, and K. Papaparaskeva, Positive para-aortic lymph nodes following pancreatectomy for pancreatic cancer. Systematic review and meta-analysis of impact on short term survival and association with clinicopathologic features, HPB, vol.18, pp.633-641, 2016.

F. Snfge, . Gercor, . Unicancer, . Sfcd, . Sfed et al., Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and followup

C. Neuzillet, S. Gaujoux, N. Williet, J. B. Bachet, L. Bauguion et al.,

, Thésaurus National de Cancérologie Digestive (TNCD)

, Dig Liver Dis, 2018.

, , vol.50, pp.1257-1271, 2020.

L. B. Van-rijssen, P. Narwade, and N. Van-huijgevoort, Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis, HPB, vol.18, pp.559-566, 2016.

C. R. Ferrone, G. Marchegiani, and T. S. Hong, Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer, Ann Surg, vol.261, pp.12-17, 2015.

K. K. Christians, S. Tsai, and A. Mahmoud, Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?, The Oncologist, vol.19, pp.266-274, 2014.

D. Dindo, N. Demartines, and P. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, vol.240, pp.205-213, 2004.

C. Bassi, G. Marchegiani, and C. Dervenis, The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After, Surgery, vol.161, pp.584-591, 2017.

S. Das, S. Ray, and V. Mangla, Post pancreaticoduodenectomy hemorrhage: A retrospective analysis of incidence, risk factors and outcome, Saudi J Gastroenterol, vol.0, p.0, 2020.

E. F. Yekebas, L. Wolfram, and G. Cataldegirmen, Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections, Ann Surg, vol.246, pp.269-280, 2007.

P. Balachandran, S. S. Sikora, R. Rao, and R. V. , Haemorrhagic complications of pancreaticoduodenectomy, ANZ J Surg, vol.74, pp.945-950, 2004.

D. J. Gouma, R. C. Van-geenen, and T. M. Van-gulik, Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume, Ann Surg, vol.232, pp.786-795, 2000.

M. N. Wente, J. A. Veit, and C. Bassi, Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition, Surgery, vol.142, pp.20-25, 2007.

Y. Tien, P. Lee, Y. , and C. , Risk factors of massive bleeding related to pancreatic leak after pancreaticoduodenectomy, J Am Coll Surg, vol.201, pp.554-559, 2005.

K. D. Lillemoe, J. L. Cameron, and J. M. Hardacre, Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial, Ann Surg, vol.230, pp.322-328, 1999.

P. J. Kneuertz, S. C. Cunningham, and J. L. Cameron, Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience, J Gastrointest Surg Off J Soc Surg Aliment Tract, vol.15, pp.1917-1927, 2011.

. Lima-sla-de, F. Bustamante, E. Moura, and . De, Endoscopic palliative treatment versus surgical bypass in malignant low bile duct obstruction: A systematic review and meta-analysis, Int J Hepatobiliary Pancreat Dis IJHPD, vol.5, pp.35-45, 2015.

J. Perinel and M. Adham, Palliative therapy in pancreatic cancer-palliative surgery, Transl Gastroenterol Hepatol, vol.4, p.28, 2019.

A. Mittal, J. Windsor, and J. Woodfield, Matched study of three methods for palliation of malignant pyloroduodenal obstruction, Br J Surg, vol.91, pp.205-209, 2004.

B. Tingstedt, B. Andersson, and C. Jönsson, First results from the Swedish National Pancreatic and Periampullary Cancer Registry, HPB, vol.21, pp.34-42, 2019.

L. Van-der-geest, V. Lemmens, and I. De-hingh, Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer, Br J Surg, vol.104, pp.1568-1577, 2017.

G. Balzano, G. Capretti, and G. Callea, Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy, HPB, vol.18, pp.470-478, 2016.

M. W. Müller, H. Friess, and J. Köninger, Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas, Am J Surg, vol.195, pp.221-228, 2008.

P. Del-valle, J. Mahvi, D. A. Fairweather, and M. , The improvement in post-operative mortality following pancreaticoduodenectomy between 2006 and 2016 is associated with an improvement in the ability to rescue patients after major morbidity, not in the rate of major morbidity